CIK: 1796224 - Address: C/O Revance Therapeutics, Inc, 1222 Demonbreun Street, 20Th Floor, Nashville, TN 37203
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/19/24 18:45
3/18/24
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSjuts Dustin STNOPS-465.040-9-5168D
6/13/23 20:09
6/9/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSjuts Dustin STNOPS-15430.820-5-3147D
5/16/23 20:29
5/15/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSjuts Dustin STNOPS-72634.550-21-12152D
3/9/23 21:45
3/9/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSjuts Dustin STNOPS-67931.590-22-15124D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact